Učitavanje...
Intravenous ferric derisomaltose for the treatment of iron deficiency anemia
Intravenous (IV) iron is the therapy of choice when oral iron is ineffective or poorly tolerated, yet use has been limited by fears of hypersensitivity reactions (HSRs). Newer formulations that bind iron more tightly and release it more slowly have made the risk of serious or severe HSRs very low. O...
Spremljeno u:
| Izdano u: | Am J Hematol |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Inc.
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8248147/ https://ncbi.nlm.nih.gov/pubmed/33580972 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.26124 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|